Newbold Ronald C 4
4 · Celldex Therapeutics, Inc. · Filed Jan 8, 2009
Insider Transaction Report
Form 4
Newbold Ronald C
Sr. VP, Business Dev.
Transactions
- Award
Common Stock
2009-01-06+5,868→ 5,868 total
Footnotes (1)
- [F1]On January 6, 2009, the Company granted 5,868 shares of Company common stock (in the form of unrestricted stock awards under the Plan) as a special bonus relating to management's performance with respect to the Merger and the integration efforts following the Merger.